uniQure N.V. (QURE) - 5i Research

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $223.32)
- $223.32 P/E (TTM): 107.17X Cap: $394.69B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,027.51)
- $1,027.51 P/E (TTM): 49.38X Cap: $971.39B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $13.99)
- $13.99 P/E (TTM): 15.13X Cap: $354M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $62.21)
- $62.21 P/E (TTM): 14.16X Cap: $7.31B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $19.51)
- $19.51 Cap: $1.35B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $23.62)
- $23.62 P/E (TTM): 13.34X Cap: $2.90B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Q: What do you think of the prospects for these companies; ITRM, QURE, CEIX

Read Answer Asked by hal on August 10, 2023